HomeNUZ • ASX
add
Neurizon Therapeutics Ltd
Previous close
$0.19
Day range
$0.18 - $0.19
Year range
$0.18 - $0.25
Market cap
86.04M AUD
Avg Volume
440.17K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | -7.82K | 82.94% |
Operating expense | 2.10M | 182.11% |
Net income | -3.64M | -17.67% |
Net profit margin | 46.59K | 589.60% |
Earnings per share | — | — |
EBITDA | -2.10M | -168.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.73M | 294.23% |
Total assets | 11.12M | 81.47% |
Total liabilities | 896.61K | -59.99% |
Total equity | 10.23M | — |
Shares outstanding | 486.22M | — |
Price to book | 9.25 | — |
Return on assets | -47.30% | — |
Return on capital | -51.45% | — |
Cash Flow
Net change in cash
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -3.64M | -17.67% |
Cash from operations | -2.56M | -244.22% |
Cash from investing | -500.00K | -2,798.38% |
Cash from financing | 5.19M | 379.25% |
Net change in cash | 2.13M | 561.51% |
Free cash flow | -1.17M | -281.91% |
About
Founded
2000
Website
Employees
4